OABI

OMNIAB INC

OABI·68218J103·US·Common Stock·Healthcare - Biotechnology-13D/G

OABI (OMNIAB INC) is held by 74 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($12.7M), VANGUARD CAPITAL MANAGEMENT LLC ($6.3M), GEODE CAPITAL MANAGEMENT, LLC ($4.6M). Net institutional sentiment: Mixed.

74
Holders
Avg rating(20 Elite)
$45.1M
Total Value
51% (81)
Fund Consensus
39 buying - 37 selling
OABISmart Money Verdict
View all
Held by 74 funds
20 elite
Who's Trading
InsiderFWFOEHR MATTHEW WSell $29KApr 7, 2026
InsiderBSBerkman Charles SSell $11KApr 7, 2026
InsiderGAGUSTAFSON KURT ASell $10KApr 7, 2026
InsiderFWFOEHR MATTHEW WSell $53KFeb 18, 2026
InsiderBSBerkman Charles SSell $17KFeb 18, 2026
InsiderGAGUSTAFSON KURT ASell $16KFeb 18, 2026
InsiderBSBerkman Charles SSell $12KFeb 17, 2026
InsiderGAGUSTAFSON KURT ASell $12KFeb 17, 2026
ActivistAXAsh X LP5.3%Feb 10, 2026
ActivistWHWhitefort Capital Management, LP9.9%Nov 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
8.1M(+0.5%)$12.7M0.0%-31.02%
28
New
4M$6.3M0.0%+32.37%
38
Increased
2.9M(+7.5%)$4.6M0.0%-33.45%
29
Increased
2.1M(+0.9%)$3.2M0.0%-59.61%
27
Decreased
1.7M(-18.9%)$2.7M0.0%-44.97%
0
Decreased
959,573(-0.7%)$1.5M0.0%-31.31%
0
New
903,799$1.4M0.0%+32.37%
35
Increased
880,895(+6.3%)$1.4M0.0%-35.69%
27
New
725,608$1.1M0.0%+32.37%
35
Increased
705,048(+355.0%)$1.1M0.0%+30.22%
41
Decreased
623,876(-28.7%)$979,4850.0%+23.94%
0
Increased
512,741(+21.2%)$805,0030.0%+31.94%
30
Decreased
419,024(-22.4%)$657,8670.0%-5.68%
0
Increased
407,933(+4.7%)$640,4540.0%-20.03%
17
Decreased
523,918(-22.2%)$629,7310.0%+15.84%
0
Decreased
380,254(-0.8%)$596,9990.0%+31.72%
0
Increased
274,451(+2.2%)$430,8880.0%-40.16%
24
Increased
269,600(+11.1%)$423,2720.0%+32.57%
27
Decreased
228,684(-19.8%)$359,0340.0%+19.18%
0
Decreased
189,536(-4.8%)$297,5720.0%-22.57%
0

Showing 1-20 of 81

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used